News Search Results
Oct 31, 2025, 06:30 ET Agriculture Biotechnology Market worth $144.25 billion by 2030- Exclusive Report by MarketsandMarkets™
chemical dependence and boost resilience against climate-related stresses. Furthermore, increasing investments in AI-integrated biotechnology, synthetic biology, and sustainable input development are expanding market potential. Browse in-depth
More news about: MarketsandMarkets
Oct 28, 2025, 10:15 ET Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR | MarketsandMarkets™
cell-free systems for complex protein production. The market also offers promising opportunities in commercial validation, vaccine development, synthetic biology, biosensor creation, and expanding into personalized medicine and therapeutic proteins. Adoption among research labs and pharmaceutical firms
More news about: MarketsandMarkets
Oct 24, 2025, 08:16 ET BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane-Reduction Strategies in Cattle
BiomEdit BiomEdit is an animal health microbial biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors Anterra Capital, Viking
More news about: BiomEdit
Oct 23, 2025, 08:00 ET Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 22, 2025, 11:16 ET UpTerra brings on new Chief Science Officer with Shiv Tiwari, Ph.D., former GreenVenus CEO and CTO
R&D. He's brought his scientific depth and leadership presence to companies including venture capital and private equity firm Third Security, synthetic biology business Intrexon, Mendel Biotechnology, and Corteva (DuPont Pioneer). Dr. Tiwari has lectured and taught at the University
More news about: UpTerra